Mehdi Mesri

Title: Mehdi Mesri: Innovator in Antibody Development

Introduction

Mehdi Mesri is a notable inventor based in Branford, CT (US), recognized for his contributions to the field of immunology. He holds 2 patents that focus on innovative approaches to antibody development, particularly targeting the TIM-1 antigen.

Latest Patents

His latest patents include the invention of antibodies against T cell immunoglobulin domain and mucin domain 1 (TIM-1) antigen and their various uses. The invention details fully human monoclonal antibodies directed to the TIM-1 antigen. It also provides isolated polynucleotide sequences encoding heavy and light chain immunoglobulin molecules. These sequences correspond to contiguous heavy and light chain sequences spanning the framework regions (FR's) and complementarity determining regions (CDR's), specifically from FR1 through FR4 or CDR1 through CDR3. Additionally, hybridomas or other cell lines expressing such immunoglobulin molecules and monoclonal antibodies are included in the patent.

Career Highlights

Throughout his career, Mehdi Mesri has worked with several prominent companies, including Curagen Corporation and Celldex Therapeutics Limited. His work in these organizations has significantly contributed to advancements in therapeutic antibody development.

Collaborations

Mehdi has collaborated with notable colleagues such as Gregory M Landes and Francine Zhifen Chen, enhancing the research and development of innovative immunological solutions.

Conclusion

Mehdi Mesri's work in antibody development, particularly concerning the TIM-1 antigen, showcases his significant contributions to the field of immunology. His patents and collaborations reflect a commitment to advancing medical science through innovative research.